Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
QURE

uniQure

$8.04

-0.16 (-1.95%)

02:55
09/14/17
09/14
02:55
09/14/17
02:55
Conference/Events
uniQure to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

QURE

uniQure

$8.20

-0.24 (-2.84%)

07:51
09/13/17
09/13
07:51
09/13/17
07:51
Conference/Events
uniQure to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

PBYI

Puma Biotechnology

$99.10

2.25 (2.32%)

, SNDX

Syndax

$12.57

-0.02 (-0.16%)

04:55
09/07/17
09/07
04:55
09/07/17
04:55
Conference/Events
Citigroup to hold a conference »

12th Annual Biotech…

PBYI

Puma Biotechnology

$99.10

2.25 (2.32%)

SNDX

Syndax

$12.57

-0.02 (-0.16%)

NSC

Norfolk Southern

$122.44

1.33 (1.10%)

BIVV

Bioverativ

$56.42

0.81 (1.46%)

MXIM

Maxim Integrated

$46.56

0.12 (0.26%)

MRTX

Mirati Therapeutics

$5.00

-0.05 (-0.99%)

ARNA

Arena Pharmaceuticals

$23.02

0.31 (1.37%)

ASMB

Assembly Biosciences

$27.61

0.46 (1.69%)

ATRA

Atara Biotherapeutics

$15.10

0.05 (0.33%)

MGNX

MacroGenics

$18.27

-0.07 (-0.38%)

PTCT

PTC Therapeutics

$21.17

-0.44 (-2.04%)

RGNX

Regenxbio

$24.45

-0.35 (-1.41%)

QURE

uniQure

$8.04

0.34 (4.42%)

TSRO

Tesaro

$129.77

-4.56 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

  • 07

    Sep

  • 08

    Sep

  • 11

    Sep

  • 12

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 24

    Oct

  • 25

    Oct

PBYI

Puma Biotechnology

$96.85

2.9 (3.09%)

, SNDX

Syndax

$12.59

-0.02 (-0.16%)

04:55
09/06/17
09/06
04:55
09/06/17
04:55
Conference/Events
Citigroup to hold a conference »

12th Annual Biotech…

PBYI

Puma Biotechnology

$96.85

2.9 (3.09%)

SNDX

Syndax

$12.59

-0.02 (-0.16%)

NSC

Norfolk Southern

$121.11

-0.05 (-0.04%)

BIVV

Bioverativ

$55.61

-0.35 (-0.63%)

MXIM

Maxim Integrated

$46.44

-0.55 (-1.17%)

MRTX

Mirati Therapeutics

$5.05

-0.05 (-0.98%)

ARNA

Arena Pharmaceuticals

$22.71

-0.38 (-1.65%)

ASMB

Assembly Biosciences

$27.15

-0.03 (-0.11%)

ATRA

Atara Biotherapeutics

$15.05

-0.2 (-1.31%)

MGNX

MacroGenics

$18.34

-0.23 (-1.24%)

PTCT

PTC Therapeutics

$21.61

0.68 (3.25%)

RGNX

Regenxbio

$24.80

2.15 (9.49%)

QURE

uniQure

$7.70

-0.28 (-3.51%)

TSRO

Tesaro

$134.33

0.73 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 08

    Sep

  • 11

    Sep

  • 12

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 24

    Oct

  • 25

    Oct

PBYI

Puma Biotechnology

$96.85

2.9 (3.09%)

, SNDX

Syndax

$12.59

-0.02 (-0.16%)

16:08
09/05/17
09/05
16:08
09/05/17
16:08
Conference/Events
Citigroup to hold a conference »

12th Annual Biotech…

PBYI

Puma Biotechnology

$96.85

2.9 (3.09%)

SNDX

Syndax

$12.59

-0.02 (-0.16%)

NSC

Norfolk Southern

$121.06

-0.1 (-0.08%)

BIVV

Bioverativ

$55.61

-0.35 (-0.63%)

MXIM

Maxim Integrated

$46.44

-0.55 (-1.17%)

MRTX

Mirati Therapeutics

$5.05

-0.05 (-0.98%)

ARNA

Arena Pharmaceuticals

$22.71

-0.38 (-1.65%)

ASMB

Assembly Biosciences

$27.15

-0.03 (-0.11%)

ATRA

Atara Biotherapeutics

$15.05

-0.2 (-1.31%)

MGNX

MacroGenics

$18.34

-0.23 (-1.24%)

PTCT

PTC Therapeutics

$21.61

0.68 (3.25%)

RGNX

Regenxbio

$24.80

2.15 (9.49%)

QURE

uniQure

$7.70

-0.28 (-3.51%)

TSRO

Tesaro

$134.33

0.73 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 08

    Sep

  • 11

    Sep

  • 12

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 24

    Oct

  • 25

    Oct

QURE

uniQure

$7.94

0.12 (1.53%)

07:06
08/28/17
08/28
07:06
08/28/17
07:06
Technical Analysis
Technical View: uniQure rallies on light volume »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

Over a month ago
QURE

uniQure

$8.09

-0.03 (-0.37%)

07:16
08/08/17
08/08
07:16
08/08/17
07:16
Earnings
uniQure reports Q2 EPS (83c), consensus (80c) »

Reports Q2 revenue $4.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$8.12

0.05 (0.62%)

, AMAG

Amag Pharmaceuticals

$20.10

1.25 (6.63%)

07:12
08/07/17
08/07
07:12
08/07/17
07:12
Hot Stocks
uniQure names Scott McMillan as COO, Sander van Deventer CSO »

uniQure N.V. (QURE)…

QURE

uniQure

$8.12

0.05 (0.62%)

AMAG

Amag Pharmaceuticals

$20.10

1.25 (6.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

QURE

uniQure

$8.09

0.14 (1.76%)

07:13
07/31/17
07/31
07:13
07/31/17
07:13
Hot Stocks
uniQure reacquires rights hemophilia B gene therapy in Europe »

uniQure announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$8.28

0.48 (6.15%)

07:15
07/21/17
07/21
07:15
07/21/17
07:15
Hot Stocks
uniQure announces 'successful' development of hemophilia gene therapy candidate »

uniQure announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.